Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease

By Katsiki Niki   Elisaf Moses  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1669-1672

Informa Healthcare

Access to resources Recommend Favorite

Monocyte chemoattractant protein-1 is related to metabolic syndrome and homocysteine in subjects without clinically significant atherosclerotic cardiovascular disease

By Kim Sang-Hwan   Lee Ji-Won   Im Jee-Aee   Hwang Hee-Jin  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 1, 2011-02 ,pp. : 1-6

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: A community‐based prospective study (Ansung‐Ansan cohort 2001–12)

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 6, 2015-11 ,pp. : 791-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic syndrome and cerebrovascular impairment in Alzheimer's disease

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 30, Iss. 12, 2015-12 ,pp. : 1164-1170

John Wiley & Sons Inc

Access to resources Recommend Favorite

The insulin resistance syndrome: implications for thrombosis and cardiovascular disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 5-6, 2003-08 ,pp. : 269-273

Karger

Access to resources Recommend Favorite